Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol. 2012;13:411–24.

Article  PubMed  CAS  Google Scholar 

Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays. 2004;26:882–93.

Article  PubMed  Google Scholar 

Smith S. The world according to PARP. Trends Biochem Sci. 2001;26:174–9.

Article  PubMed  CAS  Google Scholar 

Min A, Im SA. PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation. Cancers. 2020;12:349.

Article  Google Scholar 

Rouleau-Turcotte É, Pascal JM. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. J Biol Chem. 2023;299:105397.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature. 1992;356:356–8.

Article  PubMed  CAS  Google Scholar 

Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012;26:417–32.

Article  PubMed  PubMed Central  Google Scholar 

Jwa M, Chang P. PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. Nat Cell Biol. 2012;14:1223–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Long F, Yang D, Wang J, Wang Q, Ni T, Wei G, et al. SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation. Acta Pharm Sin B. 2021;11:1261–73.

Article  PubMed  CAS  Google Scholar 

Kim DS, Challa S, Jones A, Kraus WL. PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis. Genes Dev. 2020;34:302–20.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu H, Tang YD, Zhan G, Su C, Zheng C. The Critical Role of PARPs in regulating innate immune responses. Front Immunol. 2021;12:712556.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kunze FA, Hottiger MO. Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond. Trends Immunol. 2019;40:159–73.

Article  PubMed  CAS  Google Scholar 

Yélamos J, Moreno-Lama L, Jimeno J, Ali SO. Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies. Cancers (Basel). 2020;12:392.

Article  PubMed  Google Scholar 

Zhu H, Zheng C. When PARPs meet antiviral innate immunity. Trends Microbiol. 2021;29:776–8.

Article  PubMed  CAS  Google Scholar 

Cohen MS, Chang P. Insights into the biogenesis, function, and regulation of ADP-ribosylation. Nat Chem Biol. 2018;14:236–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang J, Gao Y, Zhang Z, Zhao J, Jia W, Xia C, et al. Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment. J Med Chem. 2022;65:16099–127.

Article  PubMed  CAS  Google Scholar 

Gupte R, Liu Z, Kraus WL. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 2017;31:101–26.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chang P, Jacobson MK, Mitchison TJ. Poly(ADP-ribose) is required for spindle assembly and structure. Nature. 2004;432:645–9.

Article  PubMed  CAS  Google Scholar 

Palazzo L, Ahel I. PARPs in genome stability and signal transduction: implications for cancer therapy. Biochem Soc Trans. 2018;46:1681–95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18:610–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Laspata N, Kaur P, Mersaoui SY, Muoio D, Liu ZS, Bannister MH, et al. PARP1 associates with R-loops to promote their resolution and genome stability. Nucleic Acids Res. 2023;51:2215–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang D, Kraus WL. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. Mol Cell. 2022;82:2315–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kraus WL. PARPs and ADP-Ribosylation: 50 Years … and Counting. Mol Cell. 2015;58:902–10.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vyas S, Chesarone-Cataldo M, Todorova T, Huang YH, Chang P. A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. Nat Commun. 2013;4:2240.

Article  PubMed  Google Scholar 

Langelier MF, Riccio AA, Pascal JM. PARP-2 and PARP-3 are selectively activated by 5’ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1. Nucleic Acids Res. 2014;42:7762–75.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Langelier MF, Planck JL, Roy S, Pascal JM. Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1. Science. 2012;336:728–32.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gagné JP, Ethier C, Defoy D, Bourassa S, Langelier MF, Riccio AA, et al. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs. DNA Repair. 2015;30:68–79.

Article  PubMed  Google Scholar 

Langelier MF, Servent KM, Rogers EE, Pascal JM. A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation. J Biol Chem. 2008;283:4105–14.

Article  PubMed  CAS  Google Scholar 

Hsiao SJ, Smith S. Tankyrase function at telomeres, spindle poles, and beyond. Biochimie. 2008;90:83–92.

Article  PubMed  CAS  Google Scholar 

Riffell JL, Lord CJ, Ashworth A. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Nat Rev Drug Discov. 2012;11:923–36.

Article  PubMed  CAS  Google Scholar 

Haikarainen T, Krauss S, Lehtio L. Tankyrases: structure, function and therapeutic implications in cancer. Curr Pharm Des. 2014;20:6472–88.

Article  PubMed  PubMed Central  CAS